Compendia Bioscience Obtains Exclusive Rights to Commercialize Oncomine(TM).ANN ARBOR Ann Arbor, city (1990 pop. 109,592), seat of Washtenaw co., S Mich., on the Huron River; inc. 1851. It is a research and educational center, with a large number of government and industrial research and development firms, many in high-technology fields such as , Mich. -- Compendia com·pen·di·a n. A plural of compendium. Bioscience, Inc., a newly formed bioinformatics company, has received exclusive rights from the University of Michigan (body, education) University of Michigan - A large cosmopolitan university in the Midwest USA. Over 50000 students are enrolled at the University of Michigan's three campuses. The students come from 50 states and over 100 foreign countries. for the development and support of Oncomine(TM), an industry leading cancer profiling database. "Compendia Bioscience is delighted to develop and commercialize Oncomine for the biotechnology and pharmaceutical industries. Building on a base of 7,000 existing users we anticipate accelerated design and functionality enhancements tailored to the specific needs of the commercial sector." said Arul M. Chinnaiyan, M.D., Ph.D., S.P. Hicks Hicks , Edward 1780-1849. American painter of primitive works, notably The Peaceable Kingdom, of which nearly 100 versions exist. Professor of Pathology and co-founder of Compendia Bioscience, Inc. "We are pleased to have this agreement," said Ken J. Nisbet, Executive Director of the University of Michigan Office of Technology Transfer, "It promotes the effective use of this vital mine of data to help researchers worldwide." The driving force behind the development of Oncomine(TM) is to collect, standardize, analyze, and deliver published cancer gene expression data to the research community. Oncomine(TM) allows users to investigate the expression of genes across thousands of cancer samples or explore genes, processes, and pathways deregulated in a particular type of cancer. Oncomine pre-computes cancer profiles, clusters, and gene set modules so scientists can focus on discovery--enhancing productivity. Oncomine(TM) has contributed to numerous important developments in cancer target discovery. The database has been cited in more than a dozen peer reviewed publications and lauded by the research community. In conjunction with the license to Oncomine(TM), Compendia Bioscience, Inc. has also received rights to HiMap (Human Interactome Map), a bioinformatics tool developed to navigate the human protein-protein interaction Protein-protein interactions refer to the association of protein molecules and the study of these associations from the perspective of biochemistry, signal transduction and networks. The interactions between proteins are important for many biological functions. network. HiMap has been integrated with Oncomine(TM), allowing users further breadth of information on targets of interest. Compendia Bioscience Overview Compendia Bioscience, Inc. advances drug target and biomarker discovery Biomarker discovery is the process by which biomarkers are discovered. It is a medical term. Many commonly used blood tests in medicine are biomarkers. The way that these tests have been found can be seen as biomarker discovery. through powerful molecular oncology tools, data, and analysis software. The Company's flagship product A primary product of a company, which is typically why the company was founded and/or what made it well known. For example, MS-DOS, Windows and the Microsoft Office suite have been flagship products of Microsoft. CorelDRAW is a flagship product of Corel Corporation. , Oncomine(TM), unifies and mines thousands of molecular oncology profiles, enabling researchers to assess target and pathway activity online in seconds. For additional information, please visit the Company's Web Site at www.compendiabio.com and the Oncomine Web Site at www.oncomine.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion